The risk of bleeding for antiplatelet agents in Haemodialysis patients: a Meta-analysis

BACKGROUND: The safety of antiplatelet therapy in haemodialysis (HD) patients remains controversial. we conducted the first meta-analysis to evaluate the bleeding risk with antiplatelet agents in these populations. METHODS: The relevant literature was searched using the following electronic database...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qi, Xie, Xiaojie, Xu, Gaosi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098092/
https://www.ncbi.nlm.nih.gov/pubmed/32216763
http://dx.doi.org/10.1186/s12882-020-01757-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098092/
https://www.ncbi.nlm.nih.gov/pubmed/32216763
http://dx.doi.org/10.1186/s12882-020-01757-1

Ejemplares similares